National Vision Holdings, Inc.

6. Revenue from Contracts with Customers

The majority of our revenues are recognized either at the point of sale or upon delivery and customer acceptance. We obtain consideration from our customers at the time of sale in cash, credit card, or on account with managed care payors having terms generally between 14 and 120 days, with most paying within 60 days. For sales of in-store non-prescription eyewear and related accessories, and paid eye exams, we recognize revenue at the point of sale. Our point in time revenues include: 1) retail sales of prescription and non-prescription eyewear, contact lenses and related accessories to retail customers (including those covered by managed care); and 2) eye exams. Revenues recognized over time primarily include product protection plans (i.e., warranties) and eye care club memberships.

The following disaggregation of revenues depicts our revenue based on the timing of revenue recognition:

Refer to Note 8. “Segment Reporting” for the Company’s disaggregation of net revenue. As our operating segments are aligned by similar economic factors, trends and customers, the reportable segment view best depicts how the nature, amount and uncertainty of revenue and cash flows are affected by economic factors.

We record reductions in revenue for estimated price concessions granted to managed care providers. The Company considers its revenue from managed care customers to include variable consideration and estimates such amounts associated with managed care customer revenues using the history of concessions provided and cash receipts from managed care providers. We reduced our net revenue for variable consideration of $2.7 million and $4.5 million during the three months ended July 4, 2026 and June 28, 2025, respectively, and $3.1 million and $7.7 million during the six months ended July 4, 2026 and June 28, 2025, respectively.

Unsatisfied Performance Obligations (Contract Liabilities)

During the three months ended July 4, 2026 and June 28, 2025, we recognized $23.7 million and $22.9 million, respectively, of deferred revenues outstanding at the beginning of each respective period. During the six months ended July 4, 2026 and June 28, 2025, we recognized $41.9 million and $40.7 million, respectively, of deferred revenues outstanding at the beginning of each respective period.

Our deferred revenue balance as of July 4, 2026 and January 3, 2026 was $87.8 million and $87.1 million, respectively. Deferred revenue recorded as of July 4, 2026 is expected to be reflected in future operating results as follows: